1 Report Prologue
2 Introduction
2.1 Scope Of Study 16
2.2 Research Objective 16
2.3 Assumptions & Limitations 17
2.3.1 Assumptions 17
2.3.2 Limitations 17
2.4 Market Structure 17
3 Research Methodology
3.1 Research Process 18
3.2 Primary Research 19
3.3 Secondary Research 19
4 Market Dynamics
4.1 Introduction 20
4.2 Drivers 20
4.2.1 Comparatively Painless And Non-Invasive Technique 20
4.2.2 Early Real Time High Precision Detection Of Diseases 20
4.2.3 Useful For Designing Effective Treatment Strategies Based On The Real Time Molecular Assessment For The Progression Of The Disease 21
4.2.4 Rise In Cases Of Cancer And Other Diseases 21
4.2.5 Lifestyle Changes And Environmental Factors 21
4.2.6 Other Advantages Over Other Techniques 22
4.2.7 The Recent Technological Advancements Has Increased The Appeal Of Liquid Biopsy 22
4.2.8 Transferability Of Liquid Biopsy 22
4.2.9 Rising Investment In Research And Developments And Collaborations Between Companies And Public Organizations 23
4.2.10 Greater Focus On Venture Capital 23
4.2.11 Demographical Factors 23
4.3 Restraints 24
4.3.1 Prohibitive Costs Associated With Liquid Biopsy 24
4.3.2 Lower Sensitivity For Certain Biomarkers 24
4.3.3 Not All Cancers Patients Benefit From Early Detection 24
4.3.4 Liquid Biopsy Is Not All Non-Invasive 24
4.3.5 Differential Awareness And Availability Between Developing And Developed World 25
4.3.6 Issues In Venture Capital, Startups, And Collaborations 25
4.4 Opportunities 25
4.4.1 Growing Collaboration Between Companies Has Become The Entrance Gateway For New Firms 25
4.4.2 Funding From Public Organizations Is A Good Strategy To Reduce Developments Costs 26
4.4.3 Rise In Research And Developments Investment 26
4.4.4 Developing Economies Provide An Unserved Market For Liquid Biopsy 26
4.4.5 Growing Trend Of Start-Ups And Venture Investment In The Field Of Liquid Biopsy 26
4.5 Challenges 27
4.5.1 Information And Interest Gap Between The Investors And The Developers 27
4.5.2 Lack Of Trained Professionals In Developing Regions 27
4.5.3 Lack Of Standardization And Transparency 27
5 Market Factor Analysis
5.1 Porterโs Five Force Analysis 28
5.1.1 Bargaining Power Of Buyer 29
5.1.2 Bargaining Power Of Supplier 30
5.1.3 Threat From Substitutes 30
5.1.4 Threat From A New Entrant 30
5.1.5 Intensity Of Competitive Rivalry 31
5.2 Value Chain Analysis 32
5.2.1 Device Manufacturers 32
5.2.2 Software Developers 32
5.2.3 Reagent And Accessory Suppliers 32
5.2.4 Healthcare Providers 32
5.2.5 Patients 32
6 Liquid Biopsy Market, By Biomarker Types
6.1 Introduction 34
6.2 Circulating Tumor Cells (CTCs) 36
6.3 Circulating Tumour DNA (CtDNA) 37
6.4 Extracellular Vesicles (EVs) 39
6.5 Other Biomarker (Circulating RNA And Proteins) 40
7 Liquid Biopsy Market, By Application
7.1 Introduction 41
7.2 Cancer 43
7.3 Reproductive Health 44
7.4 Other Therapeutic Application 45
8 Global Liquid Biopsy Market, By Sample
8.1 Introduction 47
8.2 Blood Sample 49
8.3 Urine Sample 50
8.4 Other Sample 51
9 Global Liquid Biopsy Market By End User
9.1 Introduction 52
9.2 Hospitals And Laboratories 54
9.3 Academic And Research Centres 55
9.4 Other End Users 56
10 Global Liquid Biopsy Market, By Region
10.1 Introduction 57
10.2 North America 59
Liquid Biopsy Market, By Biomarker Types
Liquid Biopsy Market, By Application
10.2.1 US
Liquid Biopsy Market, By Biomarker Types
Liquid Biopsy Market, By Application
10.2.2 Canada 68
Liquid Biopsy Market, By Biomarker Types
Liquid Biopsy Market, By Application
10.3 Europe 72
Liquid Biopsy Market, By Biomarker Types
Liquid Biopsy Market, By Application
10.3.1 Germany 77
Liquid Biopsy Market, By Biomarker Types
Liquid Biopsy Market, By Application
10.3.2 France 81
Liquid Biopsy Market, By Biomarker Types
Liquid Biopsy Market, By Application
10.3.3 UK 85
Liquid Biopsy Market, By Biomarker Types
Liquid Biopsy Market, By Application
10.3.4 Italy 89
Liquid Biopsy Market, By Biomarker Types
Liquid Biopsy Market, By Application
10.3.5 Spain 93
Liquid Biopsy Market, By Biomarker Types
Liquid Biopsy Market, By Application
10.3.6 Rest Of Europe 97
Liquid Biopsy Market, By Biomarker Types
Liquid Biopsy Market, By Application
10.4 Asia-Pacific 102
Liquid Biopsy Market, By Biomarker Types
Liquid Biopsy Market, By Application
10.4.1 Japan 107
Liquid Biopsy Market, By Biomarker Types
Liquid Biopsy Market, By Application
10.4.2 China 111
Liquid Biopsy Market, By Biomarker Types
Liquid Biopsy Market, By Application
10.4.3 India 115
Liquid Biopsy Market, By Biomarker Types
Liquid Biopsy Market, By Application
10.4.4 Australia 119
Liquid Biopsy Market, By Biomarker Types
Liquid Biopsy Market, By Application
10.4.5 South Korea 123
Liquid Biopsy Market, By Biomarker Types
Liquid Biopsy Market, By Application
10.4.6 Rest Of Asia-Pacific 127
Liquid Biopsy Market, By Biomarker Types
Liquid Biopsy Market, By Application
10.5 Middle East & Africa 132
Liquid Biopsy Market, By Biomarker Types
Liquid Biopsy Market, By Application
10.5.1 UAE 137
Liquid Biopsy Market, By Biomarker Types
Liquid Biopsy Market, By Application
10.5.2 Saudi Arabia 141
Liquid Biopsy Market, By Biomarker Types
Liquid Biopsy Market, By Application
10.5.3 Egypt 145
Liquid Biopsy Market, By Biomarker Types
Liquid Biopsy Market, By Application
10.5.4 Rest Of Middle East & Africa 149
Liquid Biopsy Market, By Biomarker Types
Liquid Biopsy Market, By Application
11 Company Profile
11.1 Guardant Health, Inc 154
11.1.1 Company Overview 154
11.1.2 Product/Business Segment Overview 154
11.1.3 Financial Overview 154
11.1.4 Key Developments 155
11.1.5 SWOT Analysis 156
11.2 Trovagene, Inc 157
11.2.1 Company Overview 157
11.2.2 Product/Business Segment Overview 157
11.2.3 Financial Overview 157
11.2.4 SWOT Analysis 158
11.3 RainDance Technologies, Inc. 159
11.3.1 Company Overview 159
11.3.2 Product/Business Segment Overview 159
11.3.3 Financial Overview 159
11.3.4 Key Developments 160
11.3.5 SWOT Analysis 160
11.4 Agena Bioscience Inc. Inc. 161
11.4.1 Company Overview 161
11.4.2 Product/Business Segment Overview 161
11.4.3 Financial Overview 161
11.4.4 Key Developments 161
11.4.5 SWOT Analysis 162
11.5 Admera Health 163
11.5.1 Company Overview 163
11.5.2 Product/Business Segment Overview 163
11.5.3 Financial Overview 163
11.5.4 Key Developments 163
11.5.5 SWOT Analysis 164
11.6 Biocept, Inc. 165
11.6.1 Company Overview 165
11.6.2 Product/Business Segment Overview 165
11.6.3 Financial Overview 165
11.6.4 Key Developments 165
11.7 Circulogene Theranostics 166
11.7.1 Company Overview 166
11.7.2 Product/Business Segment Overview 166
11.7.3 Financial Overview 166
11.7.4 Key Developments 166
11.8 Inivata Ltd 167
11.8.1 Company Overview 167
11.8.2 Product/Business Segment Overview 167
11.8.3 Financial Overview 167
11.8.4 Key Developments 167
11.9 SAGA Diagnostics AB 168
11.9.1 Company Overview 168
11.9.2 Product/Business Segment Overview 168
11.9.3 Financial Overview 168
11.9.4 Key Developments 168
11.10 Exosome Diagnostics 169
11.10.1 Company Overview 169
11.10.2 Product/Business Segment Overview 169
11.10.3 Financial Overview 169
11.10.4 Key Developments 169
12 List Of Tables
TABLE 1 GLOBAL LIQUID BIOPSY MARKET BY BIOMARKER TYPE, USD MILLION (2022-2030 ) 34
TABLE 2 CIRCULATING TUMOR CELLS (CTCS) MARKET, BY REGION, 2022-2030 (USD MILLION) 36
TABLE 3 CIRCULATING TUMOUR DNA (CTDNA) MARKET, BY REGION, 2022-2030 (USD MILLION) 38
TABLE 4 EXTRACELLULAR VESICLES (EVS) MARKET, BY REGION, 2022-2030 (USD MILLION) 39
TABLE 5 OTHER BIOMARKER TYPE MARKET, BY REGION, 2022-2030 (USD MILLION) 40
TABLE 6 GLOBAL LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2022-2030 (USD MILLION) 42
TABLE 7 CANCER THERAPEUTIC APPLICATION MARKET, BY REGION, 2022-2030 (USD MILLION) 43
TABLE 8 REPRODUCTIVE HEALTH THERAPEUTIC APPLICATION MARKET, BY REGION, 2022-2030 ($ ILLION) 44
TABLE 9 OTHER THERAPEUTIC APPLICATION MARKET, BY REGION, 2022-2030 (USD MILLION) 45
TABLE 10 GLOBAL LIQUID BIOPSY MARKET BY SAMPLE, 2022-2030 (USD MILLION) 47
TABLE 11 BLOOD SAMPLE MARKET, BY REGION, 2022-2030 (USD MILLION) 49
TABLE 12 URINE SAMPLE MARKET, BY REGION, 2022-2030 (USD MILLION) 50
TABLE 13 OTHER SAMPLE MARKET, BY REGION, 2022-2030 (USD MILLION) 51
TABLE 14 GLOBAL LIQUID BIOPSY MARKET BY END USER, 2022-2030 (USD MILLION) 52
TABLE 15 HOSPITALS AND LABORATORIES END USERS MARKET, BY REGION, 2022-2030 (USD MILLION) 54
TABLE 16 ACADEMIC AND RESEARCH CENTERS END USERS MARKET, BY REGION, 2022-2030 (USD MILLION) 55
TABLE 17 OTHER END USERS MARKET, BY REGION, 2022-2030 (USD MILLION) 56
TABLE 18 GLOBAL LIQUID BIOPSY MARKET, BY REGION, 2022-2030 (USD MILLION) 57
TABLE 19 NORTH AMERICALIQUID BIOPSY MARKET, BY COUNTRY, 2022-2030 (USD MILLION) 59
TABLE 20 NORTH AMERICA LIQUID BIOPSY MARKET, BY BIOMARKER TYPE, 2022-2030 (USD MILLION) 60
TABLE 21 NORTH AMERICA LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2022-2030 (USD MILLION) 61
TABLE 22 NORTH AMERICA LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2022-2030 (USD MILLION) 62
TABLE 23 NORTH AMERICA LIQUID BIOPSY MARKET BY END USERS 63
TABLE 24 U.S. LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2022-2030 (USD MILLION) 64
TABLE 25 U.S. LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2022-2030 (USD MILLION) 65
TABLE 26 U.S. LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2022-2030 (USD MILLION) 66
TABLE 27 U.S. LIQUID BIOPSY MARKET BY END USERS, 2022 (USD MILLION) 67
TABLE 28 CANADA LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2022-2030 (USD MILLION) 68
TABLE 29 CANADA LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2022-2030 (USD MILLION) 69
TABLE 30 CANADA LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2022-2030 (USD MILLION) 70
TABLE 31 CANADA LIQUID BIOPSY MARKET BY END USERS, 2022-2030 (USD MILLION) 71
TABLE 32 EUROPE LIQUID BIOPSY MARKET BY COUNTRY, 2022-2030 (USD MILLION) 72
TABLE 33 EUROPE LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2022-2030 (USD MILLION) 73
TABLE 34 EUROPE LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2022-2030 (USD MILLION) 74
TABLE 35 EUROPE LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2022-2030 (USD MILLION) 75
TABLE 36 EUROPE LIQUID BIOPSY MARKET BY END USERS, 2022-2030 (USD MILLION) 76
TABLE 37 GERMANY LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2022-2030 (USD MILLION) 77
TABLE 38 GERMANY LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2022-2030 (USD MILLION) 78
TABLE 39 GERMANY LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2022-2030 (USD MILLION) 79
TABLE 40 GERMANY LIQUID BIOPSY MARKET BY END USERS, 2022-2030 (USD MILLION) 80
TABLE 41 FRANCE LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2022-2030 (USD MILLION) 81
TABLE 42 FRANCE LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2022-2030 (USD MILLION) 82
TABLE 43 FRANCE LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2022-2030 (USD MILLION) 83
TABLE 44 FRANCE LIQUID BIOPSY MARKET BY END USERS, 2022-2030 (USD MILLION) 84
TABLE 45 UK LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2022-2030 (USD MILLION) 85
TABLE 46 UK LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2022-2030 (USD MILLION) 86
TABLE 47 UK LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2022-2030 (USD MILLION) 87
TABLE 48 UK LIQUID BIOPSY MARKET BY END USERS, 2022-2030 (USD MILLION) 88
TABLE 49 ITALY LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2022-2030 (USD MILLION) 89
TABLE 50 ITALY LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2022-2030 (USD MILLION) 90
TABLE 51 ITALY LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2022-2030 (USD MILLION) 91
TABLE 52 ITALY LIQUID BIOPSY MARKET BY END USERS, 2022-2030 (USD MILLION) 92
TABLE 53 SPAIN LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2022-2030 (USD MILLION) 93
TABLE 54 SPAIN LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2022-2030 (USD MILLION) 94
TABLE 55 SPAIN LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2022-2030 (USD MILLION) 95
TABLE 56 SPAIN LIQUID BIOPSY MARKET BY END USERS, 2022-2030 (USD MILLION) 96
TABLE 57 REST OF EUROPE LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2022-2030 (USD MILLION) 97
TABLE 58 REST OF EUROPE LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2022-2030 (USD MILLION) 98
TABLE 59 REST OF EUROPE LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2022-2030 (USD MILLION) 99
TABLE 60 REST OF EUROPE LIQUID BIOPSY MARKET BY END USERS, 2022-2030 (USD MILLION) 100
TABLE 61 ASIA-PACIFIC LIQUID BIOPSY MARKET BY COUNTRY, 2022-2030 (USD MILLION) 102
TABLE 62 ASIA-PACIFIC LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2022-2030 (USD MILLION) 103
TABLE 63 ASIA-PACIFIC LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2022-2030 (USD MILLION) 104
TABLE 64 ASIA-PACIFIC LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2022-2030 (USD MILLION) 105
TABLE 65 ASIA-PACIFIC LIQUID BIOPSY MARKET BY END USERS, 2022-2030 (USD MILLION) 106
TABLE 66 JAPAN LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2022-2030 (USD MILLION) 107
TABLE 67 JAPAN LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2022-2030 (USD MILLION) 108
TABLE 68 JAPAN LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2022-2030 (USD MILLION) 109
TABLE 69 JAPAN LIQUID BIOPSY MARKET BY END USERS, 2022-2030 (USD MILLION) 110
TABLE 70 CHINA LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2022-2030 (USD MILLION) 111
TABLE 71 CHINA LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2022-2030 (USD MILLION) 112
TABLE 72 CHINA LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2022-2030 (USD MILLION) 113
TABLE 73 CHINA LIQUID BIOPSY MARKET BY END USERS, 2022-2030 (USD MILLION) 114
TABLE 74 INDIA LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2022-2030 (USD MILLION) 115
TABLE 75 INDIA LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2022-2030 (USD MILLION) 116
TABLE 76 INDIA LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2022-2030 (USD MILLION) 117
TABLE 77 INDIA LIQUID BIOPSY MARKET BY END USERS, 2022-2030 (USD MILLION) 118
TABLE 78 AUSTRALIA LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2022-2030 (USD MILLION) 119
TABLE 79 AUSTRALIA LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2022-2030 (USD MILLION) 120
TABLE 80 AUSTRALIA LIQUID BIOPSY MARKET BY END USERS, 2022-2030 (USD MILLION) 122
TABLE 81 REPUBLIC OF SOUTH KOREA LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2022-2030 (USD MILLION) 123
TABLE 82 REPUBLIC OF SOUTH KOREA LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2022-2030 (USD MILLION) 124
TABLE 83 REPUBLIC OF SOUTH KOREA LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2022-2030 (USD MILLION) 125
TABLE 84 REPUBLIC OF SOUTH KOREA LIQUID BIOPSY MARKET BY END USERS, 2022-2030 (USD MILLION) 126
TABLE 85 REST OF ASIA-PACIFIC LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2022-2030 (USD MILLION) 127
TABLE 86 REST OF ASIA-PACIFIC LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2022-2030 (USD MILLION) 128
TABLE 87 REST OF ASIA-PACIFIC LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2022-2030 (USD MILLION) 129
TABLE 88 REST OF ASIA-PACIFIC LIQUID BIOPSY MARKET BY END USERS, 2022-2030 (USD MILLION) 130
TABLE 89 MIDDLE EAST & AFRICA LIQUID BIOPSY MARKET BY COUNTRY, 2022-2030 (USD MILLION) 132
TABLE 90 MIDDLE EAST & AFRICA LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2022-2030 (USD MILLION) 133
TABLE 91 MIDDLE EAST & AFRICA MARKET BY THERAPEUTIC APPLICATIONS, 2022-2030 (USD MILLION) 134
TABLE 92 MIDDLE EAST & AFRICA MARKET BY SAMPLE TYPE, 2022-2030 (USD MILLION) 135
TABLE 93 MIDDLE EAST & AFRICA MARKET BY END USERS, 2022-2030 (USD MILLION) 136
TABLE 94 UAE MARKET BY BIOMARKER TYPE, 2022-2030 (USD MILLION) 137
TABLE 95 UAE MARKET BY THERAPEUTIC APPLICATIONS, 2022-2030 (USD MILLION) 138
TABLE 96 UAE MARKET BY SAMPLE TYPE, 2022-2030 (USD MILLION) 139
TABLE 97 UAE MARKET BY END USERS, 2022-2030 (USD MILLION) 140
TABLE 98 SAUDI ARABIA MARKET BY BIOMARKER TYPE, 2022-2030 (USD MILLION) 141
TABLE 99 SAUDI ARABIA MARKET BY THERAPEUTIC APPLICATIONS, 2022-2030 (USD MILLION) 142
TABLE 100 SAUDI ARABIA MARKET BY SAMPLE TYPE, 2022-2030 (USD MILLION) 143
TABLE 101 SAUDI ARABIA MARKET BY END USERS, 2022-2030 (USD MILLION) 144
TABLE 102 EGYPT MARKET BY BIOMARKER TYPE, 2022-2030 (USD MILLION) 145
TABLE 103 EGYPT MARKET BY THERAPEUTIC APPLICATIONS, 2022-2030 (USD MILLION) 146
TABLE 104 EGYPT MARKET BY SAMPLE TYPE, 2022-2030 (USD MILLION) 147
TABLE 105 EGYPT MARKET BY END USERS, 2022-2030 (USD MILLION) 148
TABLE 106 REST OF MIDDLE EAST & AFRICA MARKET BY BIOMARKER TYPE, 2022-2030 (USD MILLION) 149
TABLE 107 REST OF MIDDLE EAST & AFRICA MARKET BY THERAPEUTIC APPLICATIONS, 2022-2030 (USD MILLION) 150
TABLE 108 REST OF MIDDLE EAST & AFRICA MARKET BY SAMPLE TYPE, 2022-2030 (USD MILLION) 151
TABLE 109 REST OF MIDDLE EAST & AFRICA MARKET BY END USERS, 2022-2030 (USD MILLION) 152
TABLE 110 GUARDANT HEALTH, INC: KEY DEVELOPMENTS 155
TABLE 111 TROVAGENE, INC CORPORATION: KEY DEVELOPMENTS 158
TABLE 112 RAINDANCE TECHNOLOGIES, INC. KEY DEVELOPMENTS 160
TABLE 113 AGENA BIOSCIENCE INC.: KEY DEVELOPMENTS 161
TABLE 114 ADMERA HEALTH: KEY DEVELOPMENTS 163
TABLE 115 BIOCEPT, INC.: KEY DEVELOPMENTS 165
TABLE 116 CIRCULOGENE THERANOSTICS: KEY DEVELOPMENTS 166
TABLE 117 INIVATA LTD: KEY DEVELOPMENTS 167
TABLE 118 TABLE 8: SAGA DIAGNOSTICS AB: KEY DEVELOPMENTS 168
TABLE 119 EXOSOME DIAGNOSTICSIS: KEY DEVELOPMENTS 169
13 List Of Figures
FIGURE 1 GLOBAL LIQUID BIOPSY: MARKET STRUCTURE 17
FIGURE 2 RESEARCH PROCESS OF MRFR 18
FIGURE 3 GLOBAL LIQUID BIOPSY: PORTER FIVE FORCES ANALYSIS 29
FIGURE 4 GLOBAL LIQUID BIOPSY MARKET, BY BIOMARKER TYPE, MARKET SHARE 2022 (%) 35
FIGURE 5 GLOBAL LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2022 USD MILLION 35
FIGURE 6 CIRCULATING TUMOR CELLS (CTCS) MARKET, BY REGION, 2022, USD MILLION 37
FIGURE 7 CIRCULATING TUMOR DNA (CTDNA) MARKET, BY REGION, 2022, USD MILLION 38
FIGURE 8 EXTRACELLULAR VESICLES (EVS) MARKET, BY REGION, 2022 USD MILLION 39
FIGURE 9 OTHER BIOMARKER TYPE MARKET, BY REGION, 2022, (USD MILLION) 40
FIGURE 10 GLOBAL LIQUID BIOPSY MARKET, BY THERAPEUTIC APPLICATIONS, MARKET SHARE 2022 (%) 42
FIGURE 11 GLOBAL LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2022, (USD MILLION) 43
FIGURE 12 CANCER THERAPEUTIC APPLICATION MARKET, BY REGION, 2022, (USD MILLION) 44
FIGURE 13 REPRODUCTIVE HEALTH THERAPEUTIC APPLICATION MARKET, BY REGION, 2022, (USD MILLION) 45
FIGURE 14 OTHER THERAPEUTIC APPLICATION MARKET, BY REGION, 2022, (USD MILLION) 46
FIGURE 15 GLOBAL LIQUID BIOPSY MARKET, BY SAMPLE, MARKET SHARE 2022 (%) 48
FIGURE 16 GLOBAL LIQUID BIOPSY MARKET BY SAMPLE, 2022, USD MILLION 48
FIGURE 17 BLOOD SAMPLE MARKET, BY REGION, 2022-2030 (USD MILLION) 49
FIGURE 18 URINE SAMPLE MARKET, BY REGION, 2022, USD MILLION 50
FIGURE 19 OTHER SAMPLE MARKET, BY REGION, 2022 (USD MILLION) 51
FIGURE 20 GLOBAL LIQUID BIOPSY MARKET, BY END USER, MARKET SHARE 2022 (%) 53
FIGURE 21 GLOBAL LIQUID BIOPSY MARKET BY END USER, 2022, USD MILLION 53
FIGURE 22 HOSPITALS AND LABORATORIES END USERS MARKET BY REGION, 2022, USD MILLION 54
FIGURE 23 ACADEMIC AND RESEARCH CENTERS END USERS MARKET, BY REGION, 2022, USD MILLION 55
FIGURE 24 OTHER END USERS MARKET, BY REGION, 2022, USD MILLION 56
FIGURE 25 GLOBAL LIQUID BIOPSY MARKET, BY REGION, MARKET SHARE 2022 (%) 58
FIGURE 26 GLOBAL LIQUID BIOPSY MARKET, BY REGION, 2022-2030 (USD MILLION) 58
FIGURE 27 NORTH AMERICA LIQUID BIOPSY MARKET, BY COUNTRY, MARKET SHARE 2022 (%) 59
FIGURE 28 NORTH AMERICA LIQUID BIOPSY MARKET, BY BIOMARKER TYPE, 2022 (USD MILLION) 60
FIGURE 29 NORTH AMERICA LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2022 (USD MILLION) 61
FIGURE 30 NORTH AMERICA LIQUID BIOPSY MARKET, BY SAMPLE TYPE, 2022 (USD MILLION) 62
FIGURE 31 NORTH AMERICALIQUID BIOPSY MARKET BY END USERS, 2022 (USD MILLION) 63
FIGURE 32 US LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2022 (USD MILLION) 64
FIGURE 33 US LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2022 (USD MILLION) 65
FIGURE 34 US LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2022 (USD MILLION) 66
FIGURE 35 US LIQUID BIOPSY MARKET BY END USERS, 2022 (USD MILLION) 67
FIGURE 36 CANADA LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2022 (USD MILLION) 68
FIGURE 37 CANADA LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2022 (USD MILLION) 69
FIGURE 38 CANADA LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2022 (USD MILLION) 70
FIGURE 39 CANADA LIQUID BIOPSY MARKET BY END USERS, 2022, (USD MILLION) 71
FIGURE 40 EUROPE LIQUID BIOPSY MARKET BY COUNTRY, MARKET SHARE 2022 (%) 72
FIGURE 41 EUROPE LIQUID BIOPSY MARKET BY COUNTRY, 2022 (USD MILLION) 73
FIGURE 42 EUROPE LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2022 (USD MILLION) 74
FIGURE 43 EUROPE LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2022 (USD MILLION) 75
FIGURE 44 EUROPE LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2022 (USD MILLION) 76
FIGURE 45 EUROPE LIQUID BIOPSY MARKET BY END USERS, 2022 (USD MILLION) 77
FIGURE 46 GERMANY LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2022 (USD MILLION) 78
FIGURE 47 GERMANY LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2022 (USD MILLION) 79
FIGURE 48 GERMANY LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2022 (USD MILLION) 80
FIGURE 49 GERMANY LIQUID BIOPSY MARKET BY END USERS, 2022 (USD MILLION) 81
FIGURE 50 FRANCE LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2022 (USD MILLION) 82
FIGURE 51 FRANCE LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2022 (USD MILLION) 83
FIGURE 52 FRANCE LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2022 (USD MILLION) 84
FIGURE 53 FRANCE LIQUID BIOPSY MARKET BY END USERS, 2022 (USD MILLION) 85
FIGURE 54 UK LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2022 (USD MILLION) 86
FIGURE 55 UK LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2022 (USD MILLION) 87
FIGURE 56 UK LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2022 (USD MILLION) 88
FIGURE 57 UK LIQUID BIOPSY MARKET BY END USERS, 2022 (USD MILLION) 89
FIGURE 58 ITALY LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2022 (USD MILLION) 90
FIGURE 59 ITALY LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2022 (USD MILLION) 91
FIGURE 60 ITALY LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2022 (USD MILLION) 92
FIGURE 61 ITALY LIQUID BIOPSY MARKET BY END USERS, 2022 (USD MILLION) 93
FIGURE 62 SPAIN LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2022 (USD MILLION) 94
FIGURE 63 SPAIN LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2022 (USD MILLION) 95
FIGURE 64 SPAIN LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2022 (USD MILLION) 96
FIGURE 65 SPAIN LIQUID BIOPSY MARKET BY END USERS, 2022 (USD MILLION) 97
FIGURE 66 REST OF EUROPE LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2022 (USD MILLION) 98
FIGURE 67 REST OF EUROPE LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2022 (USD MILLION) 99
FIGURE 68 REST OF EUROPE LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2022 (USD MILLION) 100
FIGURE 69 REST OF EUROPE LIQUID BIOPSY MARKET BY END USERS, 2022 (USD MILLION) 101
FIGURE 70 ASIA-PACIFIC LIQUID BIOPSY MARKET BY COUNTRY, MARKET SHARE 2022 (%) 102
FIGURE 71 ASIA-PACIFIC LIQUID BIOPSY MARKET BY COUNTRY, 2022 (USD MILLION) 103
FIGURE 72 ASIA-PACIFIC LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2022 (USD MILLION) 104
FIGURE 73 ASIA-PACIFIC LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2022 (USD MILLION) 105
FIGURE 74 ASIA-PACIFIC LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2022 (USD MILLION) 106
FIGURE 75 ASIA-PACIFIC LIQUID BIOPSY MARKET BY END USERS, 2022 (USD MILLION) 107
FIGURE 76 JAPAN LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2022-2030 (USD MILLION) 108
FIGURE 77 JAPAN LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2022 (USD MILLION) 109
FIGURE 78 JAPAN LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2022 (USD MILLION) 110
FIGURE 79 JAPAN LIQUID BIOPSY MARKET BY END USERS, 2022 (USD MILLION) 111
FIGURE 80 CHINA LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2022 (USD MILLION) 112
FIGURE 81 CHINA LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2022 (USD MILLION) 113
FIGURE 82 CHINA LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2022 (USD MILLION) 114
FIGURE 83 CHINA LIQUID BIOPSY MARKET BY END USERS, 2022 (USD MILLION) 115
FIGURE 84 INDIA LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2022 (USD MILLION) 116
FIGURE 85 INDIA LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2022 (USD MILLION) 117
FIGURE 86 INDIA LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2022-2030 (USD MILLION) 118
FIGURE 87 INDIA LIQUID BIOPSY MARKET BY END USERS, 2022 (USD MILLION) 119
FIGURE 88 AUSTRALIA LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2022 (USD MILLION) 120
FIGURE 89 AUSTRALIA LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2022 (USD MILLION) 121
FIGURE 90 AUSTRALIA LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2022-2030 (USD MILLION) 121
FIGURE 91 AUSTRALIA LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2022 (USD MILLION) 122
FIGURE 92 AUSTRALIA LIQUID BIOPSY MARKET BY END USERS, 2022 (USD MILLION) 123
FIGURE 93 SOUTH KOREA LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2022 (USD MILLION) 124
FIGURE 94 SOUTH KOREA LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2022 (USD MILLION) 125
FIGURE 95 SOUTH KOREA LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2022 (USD MILLION) 126
FIGURE 96 SOUTH KOREA LIQUID BIOPSY MARKET BY END USERS, 2022 (USD MILLION) 127
FIGURE 97 REST OF ASIA-PACIFIC LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2022 (USD MILLION) 128
FIGURE 98 REST OF ASIA-PACIFIC LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2022 (USD MILLION) 129
FIGURE 99 REST OF ASIA-PACIFIC LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2022 (USD MILLION) 130
FIGURE 100 REST OF ASIA-PACIFIC LIQUID BIOPSY MARKET BY END USERS, 2022 (USD MILLION) 131
FIGURE 101 MIDDLE EAST & AFRICA LIQUID BIOPSY MARKET, MARKET SHARE BY COUNTRY, 2022 (%) 132
FIGURE 102 MIDDLE EAST & AFRICA MARKET BY COUNTRY, 2022 (USD MILLION) 133
FIGURE 103 MIDDLE EAST & AFRICA MARKET BY BIOMARKER TYPE, 2022 (USD MILLION) 134
FIGURE 104 MIDDLE EAST & AFRICA MARKET BY THERAPEUTIC APPLICATIONS, 2022 (USD MILLION) 135
FIGURE 105 MIDDLE EAST & AFRICA MARKET BY SAMPLE TYPE, 2022 (USD MILLION) 136
FIGURE 106 MIDDLE EAST & AFRICA MARKET BY END USERS, 2022 (USD MILLION) 137
FIGURE 107 UAE MARKET BY BIOMARKER TYPE, 2022 (USD MILLION) 138
FIGURE 108 UAE MARKET BY THERAPEUTIC APPLICATIONS, 2022 (USD MILLION) 139
FIGURE 109 UAE MARKET BY SAMPLE TYPE, 2022 (USD MILLION) 140
FIGURE 110 UAE MARKET BY END USERS, 2022 (USD MILLION) 141
FIGURE 111 SAUDI ARABIA MARKET BY BIOMARKER TYPE, 2022 (USD MILLION) 142
FIGURE 112 SAUDI ARABIA MARKET BY THERAPEUTIC APPLICATIONS, 2022 (USD MILLION) 143
FIGURE 113 SAUDI ARABIA MARKET BY SAMPLE TYPE, 2022 (USD MILLION) 144
FIGURE 114 SAUDI ARABIA MARKET BY END USERS, 2022 (USD MILLION) 145
FIGURE 115 EGYPT MARKET BY BIOMARKER TYPE, 2022 (USD MILLION) 146
FIGURE 116 EGYPT MARKET BY THERAPEUTIC APPLICATIONS, 2022 (USD MILLION) 147
FIGURE 117 EGYPT MARKET BY SAMPLE TYPE, 2022 (USD MILLION) 148
FIGURE 118 EGYPT MARKET BY END USERS, 2022 (USD MILLION) 149
FIGURE 119 REST OF MIDDLE EAST & AFRICA MARKET BY BIOMARKER TYPE, 2022 (USD MILLION) 150
FIGURE 120 REST OF MIDDLE EAST & AFRICA MARKET BY THERAPEUTIC APPLICATIONS, 2022 (USD MILLION) 151
FIGURE 121 REST OF MIDDLE EAST & AFRICA MARKET BY SAMPLE TYPE, 2022 (USD MILLION) 152
FIGURE 122 REST OF MIDDLE EAST & AFRICA MARKET BY END USERS, 2022 (USD MILLION) 153
FIGURE 123 GUARDANT HEALTH, INC: SWOT ANALYSIS 156
FIGURE 124 TROVAGENE, INC; RECENT FINANCIALS 157
FIGURE 125 TROVAGENE, INC CORPORATION: SWOT ANALYSIS 158
FIGURE 126 RAINDANCE: RECENT FINANCIAL 159
FIGURE 127 RAINDANCE TECHNOLOGIES: SWOT ANALYSIS 160
FIGURE 128 AGENA BIOSCIENCE INC.: SWOT ANALYSIS 162
FIGURE 129 ADMERA HEALTH: SWOT ANALYSIS 164